Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam vs Diphenhydramine for Rituximab Transfusion Reaction
NCT05648058Phase 3Unknown
- Sponsor
- Ministry of Health
- Start
- Dec 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of nefopam in infusion reaction, sponsored by Ministry of Health. Status: unknown.
02
Drugs
nefopam
03
Conditions
infusion reaction
Beyond the preview
Go deeper on NCT05648058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05648058.